| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 维力医疗成立于2004年，总部及生产研发基地坐落于风景优美的广州市番禺区莲花山风景区北侧。公司主要从事麻醉、泌尿、呼吸、血液透析等领域医用导管的研发、生产和销售，产品在临床上广泛应用于手术、治疗、急救和护理等医疗领域。 公司是全球医用导管主要供应商之一，气管插管和留置导尿管的生产和销售在国际和国内名列前茅。公司与百余家国外医疗器械经销商、数十家境内医疗器械出口经销商建立了业务联系，产品销往90多个国家和地区。公司产品已经进入监管严格的北美、欧洲、日本等主流市场。在国内，产品已覆盖全国，进入了近700家三甲医院。 目前公司已取得15项美国FDA（510K）注册、74项欧盟CE产品认证、84项国内医疗器械产品注册证（其中4个III类产品注册证，73个II类产品注册证，7个I类产品备案凭证）以及21项加拿大产品注册证。 | ||||||||||||||||||||||||
| Main Business | 麻醉、导尿、泌尿外科、护理、呼吸、血液透析等领域医疗器械的研发、生产和销售 | ||||||||||||||||||||||||
| Legal Representative | 韩广源 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 陈斌 | ||||||||||||||||||||||||
| Solicitors | 北京中伦律师事务所 | ||||||||||||||||||||||||
| Auditors | 华兴会计师事务所(特殊普通合伙) | ||||||||||||||||||||||||
| Tel No | 020-39945995 | ||||||||||||||||||||||||
| Fax No | 020-39945995 | ||||||||||||||||||||||||
| Website | www.welllead.com.cn | ||||||||||||||||||||||||
| visitor@welllead.com.cn | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 02/03/2015 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.660 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.500 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 6.198 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 3.928B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |